Safe use of brain natriuretic protein to rule out the diagnosis of heart failure depends on the selection of cut off value

Heart

Volumn 91, Issue 8, 2005, Pages 1090-1091

  Williams, S G ^a   Ng, L L ^b   O'Brien, R J ^b   Barker, D ^a   Li, Y F ^a   Tan, Lip Bun ^a,c  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; EXERCISE; FEMALE; FUNCTIONAL ASSESSMENT; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; SAFETY; SENSITIVITY AND SPECIFICITY;

CASE-CONTROL STUDIES; DIAGNOSTIC ERRORS; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; NERVE TISSUE PROTEINS; PEPTIDE FRAGMENTS; REFERENCE VALUES;

EID: 23044500677     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2004.037713     Document Type: Article

References (6)

1. NICE Guideline Development and Consensus Reference Groups. The National Clinical Guideline for Diagnosis and Management of Chronic Heart Failure in Primary and Secondary Care, http://www.nice.org.uk/ cat.asp?c=79725, NICE Guideline No 5, July 2003.
2. Mark DB, Felker GM. B-type natriuretic peptide-A biomarker for all seasons? N Engl J Med 2004;350:718-20.
3. Myers J, Gullestad L, Vagelos R, et al. Cardiopulmonary exercise testing and prognosis in severe heart failure: 14 mL/kg/min revisited. Am Heart J 2000;139:78-84.
4. Lake I, Squire IB, Davies JE, et al. Reference ranges for natriuretic peptides for diagnostic use are dependent on age, gender and heart rate. Eur J Heart Fail 2003;5:599-606.
5. Cowie MR, Jourdain P, Maisel A, et al. Clinical applications of B-type natriuretic peptide (BNP) testing. Eur Heart J 2003;24:1710-8.
6. Gardner RS, Ozalp F, Murday AJ, et al. N-terminal pro-brain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failure. Eur Heart J 2003;24:1735-43.